Related Experiment Video
Updated: Sep 12, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
Evaluation of cardiac functions in patients with thalassemia major
1Department of Nuclear Medicine, Ankara University Medical School, Turkey.
Insights
Blood transfusions for thalassemia can cause heart problems. Radionuclide ventriculography (RNV) is preferred for early detection of subclinical cardiomyopathy, showing diastolic dysfunction before systolic issues appear.
Area of Science:
- Cardiology
- Hematology
- Nuclear Medicine
Background:
- Blood transfusions are vital for thalassemia patients but can lead to myocardial siderosis and dysfunction.
- Cardiac complications, including myocardial dysfunction, are a significant concern in patients with thalassemia.
Purpose of the Study:
- To evaluate myocardial perfusion using stress thallium scanning (MPS).
- To assess left ventricular functions with rest radionuclide ventriculography (RNV).
- To investigate early cardiac changes in thalassemia patients receiving regular blood transfusions.
Main Methods:
- Included 21 pediatric patients (ages 9-16) with thalassemia diagnosed 4-15 years prior.
- Patients underwent MPS and RNV within two days post-transfusion.
- Analyzed systolic and diastolic parameters of left ventricular function.
Main Results:
- MPS indicated normal perfusion in 18 patients and ischemia in 3.
- RNV showed normal systolic parameters (wall motion, ejection fraction, peak ejection rate, time to peak ejection).
- RNV revealed significantly diminished diastolic parameters (time to peak filling, peak filling rate) compared to normal values (p < 0.05).
Conclusions:
- Stress MPS may reveal ischemia or fixed defects due to cardiac involvement in thalassemia.
- RNV is a valuable tool for early detection of subclinical cardiomyopathy in these patients.
- RNV can identify diastolic abnormalities preceding systolic dysfunction in thalassemia patients.
Abstract:
It is known that a blood transfusion is necessary for survival in patients with thalassemia, but it may cause myocardial dysfunction due to myocardial siderosis as in other organs. The aim of this study was to evaluate myocardial perfusion by means of stress thallium scanning (MPS) and left ventricular functions by rest radionuclide ventriculography (RNV). Twenty-one patients at ages 9-16 (mean 12.1 +/- 3.2) who have been diagnosed with thalassemia for 4-15 years (mean 12.7 +/- 4.8) were included in the study. They had blood transfusions 78-318 times (mean 162.1 +/- 71). MPS and RNV was performed within two days after the any transfusion. MPS showed ischemia in 3 patients and normal perfusion in 18 patients. RNV revealed normal systolic parameters (wall motion, EF, PER, TPE) but diminished diastolic parameters (TPF, PFR) compared with normal values (p < 0.05). We conclude that ischemia or fixed defects may be seen in stress MPS as a result of cardiac involvement in patients with thalassemia. But, RNV is an important and preferable test for the early detection of subclinic cardiomyopathy. RNV may therefore show diastolic abnormalities before the systolic abnormalities show up.
More Related Videos
06:29Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques
Published on: June 11, 2019
10:21Evaluation of Hydration Status by Bioelectrical Impedance Vector Analysis in Patients with Ischemic Heart Disease Undergoing Exercise Stress Test
Published on: September 22, 2023
Related Concept Videos
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiovascular System Abnormal Findings I: Inspection and Palpation
Abnormal findings observed during an inspection
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Dysrhythmias V: Evaluating Dysrhythmias
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy